Today at 4 PM, Dr. Chih-Ying Lee (Postdoctoral scientist in Delecluse Lab), will focus on the intersection between DNA damage repair and innate immune response, showing us data on how type I IFN response can interfere with the repair of DNA in B cells. See you soon in ATV! 🤓 @dkfz.bsky.social

📣 On 10.7 at 4 PM, Dr. Marten Meyer (Deputy Head, Jäger Lab) and PhD student Kilian Merz (Hartmann Lab) will present new insights into personalized immunotherapy for metastatic cancer and metabolic remodeling of neutrophils in cancer. See you there! @dkfz.bsky.social

Join us on 18.7. from 13:30 to 15:00 in the ATV seminar room (ground floor) for a guest lecture by Dr. Daniel Utzschneider (Doherty Institute) on Transcriptional and environmental regulation of T cell responses to viral infection and cancer. Cutting-edge immunology- don’t miss it! @dkfz.bsky.social

📣 i² seminars are back! Join us on June 26 at 4 PM in the DKFZ Main Building where Andreas Kienzle, a PhD student from Riemer Lab, will talk about the neoepitope discovery from blood. Beers and snacks afterwards! @dkfz.bsky.social

Join us for today’s i2 seminar at 4 PM in the ATV! We’ll dive into how microRNAs shape immune checkpoint pathways and explore links between bovine products and chronic disease & cancer. Great science, good snacks, and lively discussion await!

CoViPa studies COVID-19 pathogenesis, aiming to gain knowledge on future pandemic preparedness- and AIMM will help automate biomarker assays, advancing diagnostic and therapeutic development through high-throughput, intelligent lab automation! #CoViPa #Helmholtz #PandemicPreparedness covipa.dkfz.de

From space tech to pandemic science! We're excited to have been hosting the Autonomous Intelligent Mobile Manipulator (AIMM) robot (picture below) and colleagues from the DLR Robotics Institute as part of the Helmholtz CoViPa project, bringing together immunology, virology and robotics! 🤖 🦠 🧬

Exciting news! Join us in Heidelberg, June 2–3, 2025, for the CoViPa International Symposium on Pandemic Preparedness at DKFZ. Experts will share insights on COVID-19 pathogenesis and strategies for future pandemic readiness. Looking forward to welcoming you! 🔗 covipa.dkfz.de #CoViPa #Helmholtz

Researchers at the DKFZ and the Heidelberg University Hospital have discovered that the Epstein-Barr virus increases the ability of infected immune cells to migrate. In this way, the pathogen promotes its spread in the body - a potential approach for new therapies. t1p.de/g626g

Forschende vom @crg.eu, dem @irbbarcelona.org und dem DKFZ fanden heraus: Mit dem #Alter schrumpft das Reservoir an Blutstammzellen. Es wird zunehmend von Stammzellen dominiert, die entzündungsfördernde Immunzellen hervorbringen. t1p.de/ovqqp 👇

Join us this week on Thursday (22nd May) for our next i2 seminar! This week it’s all about T cells in cancer!

Interested in SARS-CoV-2 and pandemic preparedness? Join the #covipa symposium on June 2/3 in Heidelberg/Germany, with keynotes by @marionkoopmans.bsky.social, @sanderlab.bsky.social, Florian Krammer, Gülsah Gabriel and Andreas Wack: indico.dkfz.de/event/1169/

Congratulations! 🎉 Michael Platten was nominated as ambassador in Germany for the ERC network! The newly selected ambassadors are part of an initiative to promote frontier research. Great news for science in Europe! @michael-platten.bsky.social @platten-lab.bsky.social @ercgrantees.bsky.social

🧬 New Paper out! Kathrin Wellach and Angelika Riemer from our department published a new highly sensitive cytotoxicity assay using live-cell imaging. With this method, epitope-specific T cells can be functionally analyzed for their cytotoxic capacity! 📄 Check it out: tinyurl.com/cytotoxicity...

Today is the award ceremony for Franziska Blaeschke who received the Erna Brunner Prize for her work on CAR-T cell therapies to treat solid tumors! Congratulations on this achievement! @blaeschkelab.bsky.social

Second Heidelberg Interferons Symposium coming up!! If you are based in HD or Mannheim (@dkfz.bsky.social, @uniheidelberg.bsky.social, @hlsalliance.bsky.social, @embl.org,...) and interested in any facet of these incredible #cytokines, join us on 🗓️ July 10/11 🏫 Marsilius Kolleg ✍🏻 bit.ly/IFN2025

Don’t miss our i2 seminar today at 4 pm where we will hear more about the design of human papillomavirus nanoparticle antigens and dendritic cell development in multiple myeloma. Come join us for an engaging discussion with snacks and drinks! Today at 4 PM in the main building 👇

Join us on Thursday, May 8 at 4 PM as the i2 seminars return, featuring two presentations by Dr. Ecem Kaplan, postdoctoral researcher in the Müller Lab, and Johannes Morschl, PhD student from the Autenrieth Lab. Mark your calendars and be part of an engaging discussion! @dkfz.bsky.social

Don’t miss our i2 seminar today at 4 pm where we will hear more about immunogenic cancer editopes and the lineage tree of tissue macrophage development. Join us for a lively discussion and snacks and drinks! 🧪 Today at 4pm in the main building 👇

The i2 seminars are back on Thursday, April 17, at 4 pm with two talks by Dr. Bea Casati, Postdoc in the Papavasiliou Lab, and Larissa Frank, PhD student in the Rodewald Lab. Save the date and join us for a lively discussion! @dkfz.bsky.social @beacasati.bsky.social @larissafrank.bsky.social

Don’t miss our i2 seminar today at 4 pm to learn more about vaccination therapy in glioma patients and how CAR-T cells interact with the immune system. Join us for a vibrant discussion and networking with snacks and drinks! 🧪 More details below 👇

Our i2 seminar series continues on Thursday, March 20, at 4 pm with two Data & Technique talks by Dr. Katharina Lindner, postdoc in the Platten Lab, and Dr. Oren Barboy, postdoc in the Blaeschke Lab. Save the date and join us for a lively discussion! @dkfz.bsky.social @platten-lab.bsky.social More ⬇️

Congratulations, Dr. Franziska Blaeschke! The DKFZ/KiTZ junior group leader and UKHD assistant physician was awarded the 2024 Erna Brunner Prize (€10,000) for her groundbreaking research on CAR-T cell therapies to advance the treatment of solid tumors. 👏 More: www.kitz-heidelberg.de/en/the-kitz/...

Join us today at 4 pm for our first i2@DKFZ seminar of this year. Professor Yaron Carmi from Tel Aviv University will give us new insights into the mechanism of tumor escape from immunotherapy. 🧪

Next Monday: save the date! 🧪

Our i2 DKFZ seminar series resumes on Monday, February 24, at 4 pm with a #GuestLecture by Yaron Carmi, Associate Professor in the Department of Pathology at Tel Aviv University. Save the date and join us for a lively discussion followed by snacks and drinks! @dkfz.bsky.social More details below ⬇️